Mereo BioPharma MREO Growth Metrics (2018-2026)

NASDAQ MREO
$0.30 +0.00 (+1.08%)
As of: Oct 21, 2026 · 11:36 AM EDT
Reported Financials

Mereo BioPharma Quarterly Growth Metrics

Periods 21 quarters
Latest Jun 2026

Mereo BioPharma reported asset growth of -44.57% for the quarter ended Jun 2026. These growth metrics cover 21 quarters of results from Dec 2018 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Growth MetricsGrowth Dec2018 Dec2019 Jun2020 Dec2020 Jun2021 Dec2021 Jun2022 Dec2022 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Growth Ratios
Assets Growth (1y)
32.75%-0.50%-14.10%14.87%22.14%-34.85%-39.60%-39.89%-40.56%-44.57%
Assets Growth (3y)
-11.94%-15.98%
Assets Growth (5y)
-9.78%-4.88%-6.68%-7.59%-14.26%
Assets (QoQ)
-15.88%71.85%-7.68%-13.92%-10.56%-8.33%-14.42%-14.34%-11.55%-14.53%
Cash & Equivalents Growth (1y)Cash & Equiv. Growth (1y)
-32.56%95.04%49.23%117.87%297.89%-39.17%-46.64%-42.70%-15.46%64.58%21.56%28.34%-35.81%-39.52%-41.27%-51.84%-46.34%
Cash & Equivalents Growth (3y)Cash & Equiv. Growth (3y)
-21.94%58.80%37.24%46.88%-8.76%21.53%-16.91%-18.15%-15.40%-15.49%-17.24%
Cash & Equivalents Growth (5y)Cash & Equiv. Growth (5y)
0.19%12.55%19.51%26.63%-4.31%5.08%-27.69%
Cash & Equivalents (QoQ)Cash & Equiv. (QoQ)
-15.19%79.53%-7.90%-13.31%-10.46%-10.20%-13.23%-15.83%-26.57%0.06%
Cash from Investing Activities Growth (1y)Cash from Investing Growth (1y)
-67.06%54.29%6.25%
Cash from Investing Activities Growth (3y)Cash from Investing Growth (3y)
10.54%
Cash from Investing Activities (QoQ)Cash from Investing (QoQ)
100.14%
Cash from Operations Growth (1y)Cash from Ops. Growth (1y)
13.59%-1.93%-382.78%-38.75%-4.23%3.20%2.79%18.45%48.23%21.02%
Cash from Operations Growth (3y)Cash from Ops. Growth (3y)
22.46%7.97%
Cash from Operations (QoQ)Cash from Ops. (QoQ)
16.15%134.29%-355.32%-17.71%1.09%4.87%-25.28%11.58%8.14%4.47%-5.10%43.87%-40.14%
EBIT Growth (1y)
13.23%-1,480.02%-3.37%-114.30%-13.15%18.07%-6.85%45.07%21.75%33.04%
EBIT Growth (3y)
8.41%-105.42%
EBIT (QoQ)
92.89%-1,018.00%21.39%-38.89%-29.43%26.85%-62.97%26.66%6.28%4.61%16.23%-4.48%19.80%
EBT Growth (1y)
25.88%-599.89%-129.69%26.92%-43.97%-19.27%53.18%-4.33%47.86%52.07%
EBT Growth (3y)
17.75%-58.75%
EBT (QoQ)
85.50%-272.99%-47.62%7.16%-36.91%-22.41%53.03%-82.90%-13.42%51.94%-4.66%8.60%-4.26%
EPS (Basic) Growth (1y)
33.96%-517.93%-104.29%31.03%-28.55%-6.19%54.92%3.20%49.00%52.32%
EPS (Basic) Growth (3y)
24.35%-46.26%
EPS (Basic) (QoQ)
85.60%-242.19%-44.87%7.46%-34.70%-13.13%51.09%-72.48%-11.27%51.97%-5.03%9.13%-4.03%
EPS (Diluted) Growth (1y)
33.96%-517.93%-104.29%31.03%-28.55%-6.19%54.92%3.20%49.00%52.32%
EPS (Diluted) Growth (3y)
24.35%-46.26%
EPS (Diluted) (QoQ)
85.60%-242.19%-44.87%7.46%-34.70%-13.13%51.09%-72.48%-11.27%51.97%-5.03%9.13%-4.03%
Free Cash Flow Growth (1y)FCF Growth (1y)
13.59%-1.93%-382.78%-38.75%-4.48%3.20%2.79%18.45%48.35%21.02%
Free Cash Flow Growth (3y)FCF Growth (3y)
22.46%7.97%
Free Cash Flow (QoQ)FCF (QoQ)
16.15%134.29%-355.32%-17.71%1.09%4.87%-25.28%11.37%8.36%4.47%-5.10%43.87%-40.14%
Gross Profit (QoQ)
1,705.19%-104.22%641.70%
Interest Coverage Ratio Growth (1y)Interest Cover Growth (1y)
-123.91%-4,811.92%-104.99%-101.72%-94.87%-1,030.00%-1,247.07%-795.54%-604.28%-0.44%
Interest Coverage Ratio Growth (3y)Interest Cover Growth (3y)
-213.23%-723.02%
Interest Coverage Ratio (QoQ)Interest Cover (QoQ)
94.47%-1,543.46%-55.89%-58.15%-21.22%31.41%-53.41%-52.78%-602.93%18.24%-1.99%-20.15%-0.25%
Net Cash Flow Growth (1y)NCF Growth (1y)
10.10%601.39%-176.79%-39.34%5.34%-120.02%13.61%19.21%43.94%22.38%
Net Cash Flow Growth (3y)NCF Growth (3y)
21.86%7.97%
Net Cash Flow (QoQ)NCF (QoQ)
19.79%236.25%-164.26%-28.02%547.34%-120.87%-16.60%13.03%5.37%9.97%-9.05%39.66%-31.03%
Net Income Growth (1y)
25.88%-599.89%-129.69%22.65%-43.97%-19.27%53.18%-4.33%47.86%52.07%
Net Income Growth (3y)
17.75%-58.75%
Net Income (QoQ)
85.50%-272.99%-39.47%1.73%-36.91%-22.41%53.03%-82.90%-13.42%51.94%-4.66%8.60%-4.26%
Net Income towards Common Stockholders Growth (1y)Net Income Growth (1y)
25.88%-599.89%-129.69%22.65%-43.97%-19.27%53.18%-4.33%47.86%52.07%
Net Income towards Common Stockholders Growth (3y)Net Income Growth (3y)
17.75%-58.75%
Net Income towards Common Stockholders (QoQ)Net Income (QoQ)
85.50%-272.99%-39.47%1.73%-36.91%-22.41%53.03%-82.90%-13.42%51.94%-4.66%8.60%-4.26%
Operating Income Growth (1y)Op. Inc Growth (1y)
13.23%-1,480.02%-3.37%-114.30%-13.15%18.07%-6.85%45.07%21.75%33.04%
Operating Income Growth (3y)Op. Inc Growth (3y)
8.41%-105.42%
Operating Income (QoQ)Op. Inc (QoQ)
92.89%-1,018.00%21.39%-38.89%-29.43%26.85%-62.97%26.66%6.28%4.61%16.23%-4.48%19.80%
Profit After Tax Growth (1y)PAT Growth (1y)
25.88%-599.89%-129.69%22.65%-43.97%-19.27%53.18%-4.33%47.86%52.07%
Profit After Tax Growth (3y)PAT Growth (3y)
17.75%-58.75%
Profit After Tax (QoQ)PAT (QoQ)
85.50%-272.99%-39.47%1.73%-36.91%-22.41%53.03%-82.90%-13.42%51.94%-4.66%8.60%-4.26%
Property, Plant & Equipment (Net) Growth (1y)PP&E (Net) Growth (1y)
7,913.38%-16.79%-85.85%-76.06%59.28%-22.48%-35.36%-23.02%-81.65%-82.88%-36.54%-31.39%-35.50%-44.76%-46.69%-63.16%-75.23%
Property, Plant & Equipment (Net) Growth (3y)PP&E (Net) Growth (3y)
118.46%162.35%-46.35%-47.39%-47.72%-42.62%-53.25%-57.78%-56.03%-60.41%-69.87%
Property, Plant & Equipment (Net) Growth (5y)PP&E (Net) Growth (5y)
60.75%16.45%-54.11%-55.75%-56.39%-42.31%-56.09%
Property, Plant & Equipment (Net) (QoQ)PP&E (Net) (QoQ)
-11.11%-6.11%-6.80%-18.41%-3.89%-11.74%-20.18%-21.26%-33.58%-40.66%
Return on Assets [ROA] Growth (1y)ROA Growth (1y)
0.00M0.00M0.00M0.00M0.00M107.00
Return on Assets [ROA] (QoQ)ROA (QoQ)
-543.00-56.00-336.000.00M0.00M414.000.00M162.00793.00
Return on Capital Employed [ROCE] Growth (1y)ROCE Growth (1y)
0.00M0.00M0.00M0.00M0.00M0.00M
Return on Capital Employed [ROCE] (QoQ)ROCE (QoQ)
0.00M0.00M0.00M-611.00-499.000.00M197.000.00M-535.00
Return on Equity [ROE] Growth (1y)ROE Growth (1y)
0.00M0.00M0.14M0.00M-289.00
Return on Equity [ROE] (QoQ)ROE (QoQ)
-42.00-424.00-0.14M-877.00423.000.00M44.00564.00
Return on Invested Capital [ROIC] (QoQ)ROIC (QoQ)
-472.00-0.04M
Return on Sales [ROS] Growth (1y)ROS Growth (1y)
-0.39M0.18M-1.08M-30.88M
Return on Sales [ROS] Growth (3y)ROS Growth (3y)
-31.09M
Return on Sales [ROS] (QoQ)ROS (QoQ)
0.04M-0.36M0.00M-1.26M0.22M-6.72M-23.12M
Revenue Growth (1y)
106.11%
Revenue (QoQ)
377.78%
Share-based Compensation Growth (1y)Stock Comp. Growth (1y)
25.38%121.42%13.39%85.89%11.12%-1.10%-1.38%1.85%-29.54%-36.22%
Share-based Compensation Growth (3y)Stock Comp. Growth (3y)
-0.62%11.78%
Share-based Compensation (QoQ)Stock Comp. (QoQ)
-42.32%62.35%-46.77%151.53%1.85%-16.86%-12.73%50.36%-9.35%-17.09%-9.87%4.02%-17.94%
Total Debt Growth (1y)
-1.37%36.61%-18.20%-27.36%-11.76%-22.04%-31.17%-48.82%-50.21%
Total Debt Growth (3y)
-7.60%-10.71%-8.20%-20.80%-33.82%-41.65%-34.19%
Total Debt Growth (5y)
-13.68%-27.73%-27.11%
Total Debt (QoQ)
6.50%12.57%-0.29%

Mereo BioPharma Growth Metrics API

Pull Mereo BioPharma's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=MREO&statement=Growth&frequency=Quarter&period=all&api_key=YOUR_API_KEY